InflaRx Research Development vs Total Operating Expenses Analysis

IFRX Stock  USD 2.36  0.05  2.16%   
InflaRx NV financial indicator trend analysis is infinitely more than just investigating InflaRx NV recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InflaRx NV is a good investment. Please check the relationship between InflaRx NV Research Development and its Total Operating Expenses accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.

Research Development vs Total Operating Expenses

Research Development vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InflaRx NV Research Development account and Total Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.
The correlation between InflaRx NV's Research Development and Total Operating Expenses is 0.97. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of InflaRx NV, assuming nothing else is changed. The correlation between historical values of InflaRx NV's Research Development and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of InflaRx NV are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Research Development i.e., InflaRx NV's Research Development and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.97
Relationship DirectionPositive 
Relationship StrengthVery Strong

Research Development

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most indicators from InflaRx NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InflaRx NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InflaRx NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.Sales General And Administrative To Revenue is likely to rise to 212.95 in 2024, whereas Selling General Administrative is likely to drop slightly above 10.1 M in 2024.

InflaRx NV fundamental ratios Correlations

-0.760.530.830.990.680.980.74-0.58-0.70.760.590.460.270.980.60.940.38-0.76-0.760.320.480.91-0.510.40.56
-0.76-0.45-0.7-0.84-0.55-0.84-0.670.330.65-0.63-0.34-0.38-0.22-0.73-0.54-0.83-0.351.01.0-0.31-0.47-0.80.91-0.33-0.52
0.53-0.450.790.50.310.540.840.08-0.770.24-0.060.82-0.170.370.510.610.81-0.47-0.460.260.940.73-0.130.790.56
0.83-0.70.790.80.520.820.97-0.15-0.90.730.160.75-0.080.710.720.910.74-0.71-0.70.420.730.95-0.340.680.73
0.99-0.840.50.80.691.00.72-0.59-0.680.750.60.430.30.980.570.950.34-0.84-0.840.30.460.9-0.630.370.53
0.68-0.550.310.520.690.680.5-0.08-0.440.560.080.22-0.310.690.480.590.39-0.54-0.540.230.230.59-0.410.170.39
0.98-0.840.540.821.00.680.75-0.57-0.710.770.580.430.290.960.590.960.4-0.84-0.840.320.50.93-0.620.370.55
0.74-0.670.840.970.720.50.75-0.01-0.90.670.020.7-0.210.620.670.850.77-0.68-0.670.330.830.91-0.310.630.68
-0.580.330.08-0.15-0.59-0.08-0.57-0.01-0.02-0.27-1.00.03-0.88-0.670.09-0.440.40.320.330.120.08-0.310.360.040.11
-0.70.65-0.77-0.9-0.68-0.44-0.71-0.9-0.02-0.680.0-0.620.14-0.59-0.9-0.81-0.820.670.66-0.67-0.76-0.90.31-0.56-0.9
0.76-0.630.240.730.750.560.770.67-0.27-0.680.280.140.030.760.690.810.43-0.64-0.640.480.220.78-0.410.060.64
0.59-0.34-0.060.160.60.080.580.02-1.00.00.28-0.020.880.67-0.080.46-0.38-0.33-0.34-0.12-0.060.32-0.36-0.03-0.1
0.46-0.380.820.750.430.220.430.70.03-0.620.14-0.02-0.130.290.420.510.64-0.4-0.390.240.680.6-0.071.00.48
0.27-0.22-0.17-0.080.3-0.310.29-0.21-0.880.140.030.88-0.130.34-0.190.19-0.48-0.22-0.22-0.07-0.160.09-0.35-0.11-0.17
0.98-0.730.370.710.980.690.960.62-0.67-0.590.760.670.290.340.510.890.22-0.73-0.730.260.340.83-0.530.230.46
0.6-0.540.510.720.570.480.590.670.09-0.90.69-0.080.42-0.190.510.640.73-0.55-0.540.90.430.74-0.250.370.99
0.94-0.830.610.910.950.590.960.85-0.44-0.810.810.460.510.190.890.640.53-0.83-0.830.340.610.98-0.560.440.61
0.38-0.350.810.740.340.390.40.770.4-0.820.43-0.380.64-0.480.220.730.53-0.37-0.350.560.720.68-0.020.60.75
-0.761.0-0.47-0.71-0.84-0.54-0.84-0.680.320.67-0.64-0.33-0.4-0.22-0.73-0.55-0.83-0.371.0-0.32-0.48-0.810.9-0.34-0.53
-0.761.0-0.46-0.7-0.84-0.54-0.84-0.670.330.66-0.64-0.34-0.39-0.22-0.73-0.54-0.83-0.351.0-0.31-0.47-0.80.9-0.33-0.52
0.32-0.310.260.420.30.230.320.330.12-0.670.48-0.120.24-0.070.260.90.340.56-0.32-0.310.140.45-0.110.220.91
0.48-0.470.940.730.460.230.50.830.08-0.760.22-0.060.68-0.160.340.430.610.72-0.48-0.470.140.7-0.190.640.46
0.91-0.80.730.950.90.590.930.91-0.31-0.90.780.320.60.090.830.740.980.68-0.81-0.80.450.7-0.50.530.72
-0.510.91-0.13-0.34-0.63-0.41-0.62-0.310.360.31-0.41-0.36-0.07-0.35-0.53-0.25-0.56-0.020.90.9-0.11-0.19-0.5-0.03-0.22
0.4-0.330.790.680.370.170.370.630.04-0.560.06-0.031.0-0.110.230.370.440.6-0.34-0.330.220.640.53-0.030.43
0.56-0.520.560.730.530.390.550.680.11-0.90.64-0.10.48-0.170.460.990.610.75-0.53-0.520.910.460.72-0.220.43
Click cells to compare fundamentals

InflaRx NV Account Relationship Matchups

InflaRx NV fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets121.6M88.2M125.1M102.4M120.2M106.8M
Short Long Term Debt Total846.0K559.0K1.4M1.4M1.1M1.1M
Other Current Liab1.1M117.7K8.4M7.7M4.5M2.8M
Total Current Liabilities14.1M10.1M18.8M13.0M16.8M10.7M
Total Stockholder Equity107.1M77.9M105.3M88.3M102.7M86.6M
Other Liab67.9K39.0K33.3K35.0K40.3K37.6K
Net Tangible Assets151.2M106.7M77.5M105.0M120.8M81.2M
Property Plant And Equipment Net1.4M955.0K1.7M1.6M1.4M988.9K
Net Debt(32.3M)(25.4M)(24.8M)(14.9M)(11.6M)(12.2M)
Retained Earnings(134.4M)(168.3M)(214.0M)(243.5M)(286.1M)(271.8M)
Accounts Payable12.4M8.3M1.7M5.0M12.0M6.4M
Cash33.1M26.0M26.2M16.3M12.8M12.1M
Non Current Assets Total2.6M1.9M29.5M5.0M10.7M6.3M
Non Currrent Assets Other452.2K353.5K336.6K308.1K283.2K381.2K
Other Assets(2.0)353.5K336.6K(8.9K)(8.0K)(7.6K)
Cash And Short Term Investments115.5M81.1M83.4M81.8M90.3M93.4M
Common Stock Total Equity2.9M3.1M3.1M3.4M3.9M2.3M
Common Stock Shares Outstanding26.0M27.1M41.6M44.2M54.9M33.6M
Short Term Investments82.4M55.2M57.2M65.5M77.5M53.6M
Liabilities And Stockholders Equity121.6M88.2M125.1M102.4M120.2M106.8M
Non Current Liabilities Total369.8K253.8K1.1M1.0M782.6K743.5K
Capital Lease Obligations845.9K559.0K1.4M1.4M1.1M649.5K
Other Current Assets1.3M3.7M11.0M14.2M4.0M4.3M
Other Stockholder Equity213.2M216.6M283.4M289.8M341.7M210.9M
Total Liab14.4M10.4M19.9M14.1M17.6M14.7M
Long Term Investments272.6K272.3K27.2M2.9M9.1M4.9M
Property Plant And Equipment Gross1.4M955.0K1.7M1.6M4.3M4.5M
Total Current Assets119.0M86.3M95.7M97.4M109.5M100.6M
Accumulated Other Comprehensive Income25.1M26.3M30.6M36.6M40.1M30.9M
Non Current Liabilities Other(1.0)33.3K35.0K36.9K42.4K44.5K
Short Term Debt515.2K338.5K366.2K369.4K374.3K275.1K
Intangible Assets452.4K350.2K235.2K138.9K42.8K40.7K
Common Stock3.1M3.4M5.3M5.4M7.1M3.7M
Property Plant Equipment624.7K1.4M955.0K1.7M1.9M2.0M
Net Invested Capital107.1M77.9M105.3M88.3M102.6M85.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.